Skip to main content
Press release October 9, 2026

Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV a

Arcutis Biotherapeutics, Inc. (ARQT)

We couldn't retrieve the full text for this release. Read it on the company's site.

Read full release on company site